PRED - Predictive Technology Group, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.01
+0.01 (+1.05%)
At close: 3:58PM EST
Stock chart is not supported by your current browser
Previous Close1.00
Open0.99
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.99 - 1.06
52 Week Range0.76 - 3.87
Volume153,780
Avg. Volume195,009
Market Cap243.161M
Beta (3Y Monthly)0.55
PE Ratio (TTM)N/A
EPS (TTM)-6.94
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire18 days ago

    Predictive Technology Group Appoints Industry Veteran John E. Sorrentino as Chairman

    Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that John E. Sorrentino has been named Chairman of the Board in addition to his role as Chair of the Predictive Scientific Advisory Board. Sorrentino has more than 35 years of senior management experience in the life sciences industry and serves as Vice President and Chief Operating Officer of Pfizer Vaccine Research and Development.

  • GlobeNewswirelast month

    Predictive Technology Group Appoints Charles Andres to Its Scientific Advisory Board

    SALT LAKE CITY, Oct. 18, 2018 -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic.

  • GlobeNewswirelast month

    Predictive Technology Group Acquires Regenerative Medical Technologies, Inc.

    Concurrent with the acquisition of RMT, Rick Obray, M.D. joins as Chairman of the Predictive Clinical Advisory Board. Dr. Obray received his Doctor of Medicine degree from Johns Hopkins University School of Medicine.

  • GlobeNewswirelast month

    Juneau Biosciences Presents New Genetic Discoveries in Endometriosis at ASRM Scientific Congress & Expo

    Predictive Technology Group, Inc. (OTC/PINK: PRED) (“Predictive”), reports that Kenneth Ward, M.D., CEO of Juneau Biosciences, LLC, presented new scientific discoveries concerning the genetics of endometriosis at the 74th American Society of Reproductive Medicine (ASRM) Scientific Congress & Expo underway in Denver, Colo.  Juneau Biosciences is a majority-owned subsidiary of Predictive. On October 10 representatives from Juneau will make three additional scientific presentations based on data from Predictive’s Genealogy Database (GenDB™), exploring the use of extended family trees in disease gene discovery.  Two of these presentations examine the lineage of families with the largest presence of genes linked to endometriosis reported to date.  One family tree spans 19 generations and includes over 250 women living with surgically-confirmed endometriosis, all descendants of a man born in 1608.  Data from GenDB suggests that more than 1 million women in the United States may carry this family’s risk factor.

  • GlobeNewswirelast month

    Predictive Diagnostics Launches Endometriosis Risk Test

    Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification enabling revolutionary therapeutic approaches, announces that its subsidiary, Predictive Diagnostics, will launch a unique endometriosis risk test this weekend at the 74th American Society of Reproductive Medicine (ASRM) Scientific Congress & Expo in Denver, Colorado. The test, ARTguide™, is a first-in-class non-invasive diagnostic test for endometriosis and other genetic causes of infertility.  ARTguide™ is indicated for the hundreds of thousands of women considering use of Assisted Reproductive Technologies (ART) such as In Vitro Fertilization (commonly referred to as IVF).  Next generation sequencers will be used to test the patient for variants in 11 genes known to impact human fertility.  Additionally, over 750 DNA markers associated with endometriosis are tested using a proprietary algorithm.

  • GlobeNewswire2 months ago

    Predictive Technology Group Acquires Key DNA and Ancestry Assets

    Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through unique biotechnology treatments, announces that it has acquired DNA and ancestry assets, including significant genetic data related to women’s diseases and degenerative disc disease from Taueret Laboratories, LLC. “Although our focus remains on endometriosis, the acquisition of these key DNA and ancestry assets significantly strengthens our development platforms to commercialize gene-based diagnostics and biotechnology treatments for other debilitating diseases, such as additional difficult-to-diagnose women’s health diseases and degenerative disc disease,” said Bradley Robinson, CEO of Predictive Technology Group.

  • GlobeNewswire2 months ago

    Predictive Technology Group Acquires Inception Dx

    Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through unique biotechnology treatments, announces that it has acquired Inception Dx. Inception Dx will operate as a wholly owned subsidiary of Predictive Technology Group. The acquisition of Utah-based Inception Dx includes next-generation sequencing and genotyping assets along with extensive protocols, quality and laboratory management systems and other resources required by a “high complexity” molecular diagnostic laboratory operating under the Clinical Laboratory Improvement Act (CLIA).

  • Zacks Small Cap Research2 months ago

    PRED: Early Diagnosis Can Save 1 in 10 Women

    Endometriosis affects an estimated 200 million women worldwide and is frequently misdiagnosed, preventing its early and proper treatment. Failing to properly identify and treat endometriosis typically results in irreversible periodic intense pain, infertility, bowel and urinary disorders and other discomfort. As of today, there are no lab tests available to diagnose endometriosis.

  • GlobeNewswire2 months ago

    Predictive Technology Group to Present at Two Upcoming Investment Conferences

    SALT LAKE CITY, Sept. 21, 2018-- Predictive Technology Group, Inc., a life-sciences technology company, announces that Bradley Robinson, President and CEO, will present a corporate update at two upcoming ...

  • GlobeNewswire2 months ago

    Predictive Technology Group Announces Opening of New Laboratory Facilities

    Predictive Technology Group, Inc. (OTC/PINK: PRED), a life-sciences technology company, announces its subsidiary Predictive Biotech has completed phase one of its new laboratory facility. The new lab, located in Research Park on the University of Utah campus, features an ISO clean room and meets Good Tissue Practices (GTP) and Good Manufacturing Practices (GMP) requirements for the company’s human cell and tissue products (HCT/Ps). “We are very pleased with the new facility,” said Eric Olson, Predictive Biotech’s CEO.

  • GlobeNewswire2 months ago

    Predictive Technology Group Announces Updated Presentation Time at the H.C. Wainwright 20th Annual Global Investment Conference

    SALT LAKE CITY, Sept. 05, 2018-- Predictive Technology Group, Inc., a life-sciences technology company, announces that its presentation time at the H.C. Wainwright 20 th Annual Global Investment Conference ...

  • GlobeNewswire3 months ago

    Predictive Technology Group to Present at H.C. Wainwright 20th Annual Global Investment Conference

    SALT LAKE CITY, Aug. 30, 2018-- Predictive Technology Group, Inc., a life-sciences technology company, announces that Bradley Robinson, President and CEO, will present a corporate update at the H.C. Wainwright ...